BAX and cancer: We suggest that the anti-cancer effect of MET combined with either antifolate agent occurs through the inhibition of cancer cell progression, increase expression of p53 and Bax, decrease expression of Bcl-2, rise in the number of total apoptotic cells, inhibition of migration ability, decrease in ATP production, inhibition of the glycolysis pathway and induction of mitochondrial damage.